Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial is a research paper published in Contemporary Clinical Trials Communications (2024). On theSindex it has a DataRank of 0.308. It has been cited 5 times, with 1 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0.0389
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 1 citer.
National Institute of Child Health and Human Development
Grant: 1R01HD096559
NICHD NIH HHS
Grant: R01 HD096559
National Institutes of Health
Grant: 3R01HD096559-05S1
Burden and Risk of Neurological and Cognitive Impairment in Pediatric Sickle Cell Anemia in Uganda (BRAIN SAFE II)
National Institutes of Health Fogarty International Center
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health and Human Development
FWCI
1.38
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals